Search





Search





Markets
/
Stocks
/
allr
/

Allarity Therapeutics Inc

ALLR

Add to Watchlist

1.210USD

-0.020-1.63%

Close 07-31 16:00（ET）Quotes delayed by 15 min

19.46MMarket Cap

LossP/E TTM

Allarity Therapeutics Inc

1.210

-0.020-1.63%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ALLR Cash Flow Statement

You can access the annual and quarterly cash flow statements of Allarity Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-67.27%-4.49M

-1.15%-3.24M

37.35%-3.41M

24.04%-5.48M

-91.99%-2.69M

-91.75%-3.21M

8.78%-5.44M

-189.10%-7.22M

56.29%-1.40M

31.64%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

43.37%-2.45M

---4.41M

---4.21M

---5.75M

---4.32M

Net income from continuing operations

-0.66%-2.75M

54.74%-3.37M

75.79%-2.81M

-42.42%-2.32M

28.91%-2.73M

-332.81%-7.45M

-160.63%-11.59M

31.55%-1.63M

-14.65%-3.84M

39.32%-1.72M

11.71%-4.45M

53.36%-2.38M

-8.83%-3.35M

83.12%-2.84M

---5.04M

---5.10M

---3.08M

---16.82M

Operating gains losses

----

-100.00%0.00

----

1100.00%12.00K

450.00%11.00K

-88.89%1.00K

107766.67%9.71M

-88.89%1.00K

-80.00%2.00K

-99.75%9.00K

-18.18%9.00K

-62.50%9.00K

-99.93%10.00K

22187.50%3.57M

--11.00K

--24.00K

--14.03M

--16.00K

Deferred tax

----

--0.00

100.00%0.00

--0.00

100.00%0.00

-100.00%0.00

---432.00K

--0.00

---14.00K

135.93%97.00K

100.00%0.00

-100.00%0.00

100.00%0.00

-114.29%-270.00K

---119.00K

--4.00K

---1.23M

---126.00K

Other non-cash items

-116.67%-26.00K

1185.34%1.26M

-33.33%-44.00K

-101.01%-1.00K

84.21%-12.00K

56.55%-116.00K

-122.45%-33.00K

253.57%99.00K

12.64%-76.00K

46.06%-267.00K

137.40%147.00K

-97.41%28.00K

-134.12%-87.00K

-2162.50%-495.00K

---393.00K

--1.08M

--255.00K

--24.00K

Change in working capital

-1224.16%-1.97M

-133.15%-1.29M

74.14%-816.00K

4.34%-3.42M

-105.16%-149.00K

12.31%3.91M

-73.79%-3.16M

-419.48%-3.58M

405.60%2.89M

273.58%3.48M

-403.68%-1.82M

70.32%1.12M

122.71%571.00K

-85.84%931.00K

--598.00K

--657.00K

---2.51M

--6.58M

-Change in receivables

37.39%-216.00K

-9.75%796.00K

27.40%-53.00K

-99.19%-494.00K

33.14%-345.00K

17.91%882.00K

-508.33%-73.00K

66.44%-248.00K

-2143.48%-516.00K

-4.96%748.00K

93.81%-12.00K

-435.51%-739.00K

94.95%-23.00K

33.62%787.00K

---194.00K

---138.00K

---455.00K

--589.00K

-Change in prepaid expenses

-10035.71%-1.39M

11.80%-314.00K

-304.19%-439.00K

-590.91%-864.00K

-94.14%14.00K

7.53%-356.00K

222.16%215.00K

-53.32%176.00K

4083.33%239.00K

-231.90%-385.00K

-145.71%-176.00K

10.88%377.00K

99.51%-6.00K

-243.21%-116.00K

--385.00K

--340.00K

---1.23M

--81.00K

-Change in other current assets

3040.00%157.00K

-913.33%-152.00K

-90.32%3.00K

71.43%-6.00K

-94.95%5.00K

-101.83%-15.00K

-94.42%31.00K

-200.00%-21.00K

621.05%99.00K

155.97%820.00K

1584.85%556.00K

93.91%-7.00K

-104.04%-19.00K

-528.76%-1.47M

--33.00K

---115.00K

--470.00K

---233.00K

-Change in other current liabilities

----

--207.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-67.27%-4.49M

-1.15%-3.24M

37.35%-3.41M

24.04%-5.48M

-91.99%-2.69M

-91.75%-3.21M

8.78%-5.44M

-189.10%-7.22M

56.29%-1.40M

31.64%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

43.37%-2.45M

---4.41M

---4.21M

---5.75M

---4.32M

Investing cash flow

Net cash from continuing investing activities

--64.00K

-97.32%8.00K

----

--298.00K

----

-100.00%0.00

--0.00

100.00%0.00

460.00%18.00K

--0.00

---809.00K

---5.00K

Capital expenditures

--64.00K

-97.32%8.00K

----

--298.00K

----

--18.00K

----

Net cash flow from disposal of fixed assets

--64.00K

-97.32%8.00K

----

--298.00K

----

-100.00%0.00

--0.00

100.00%0.00

460.00%18.00K

--0.00

---809.00K

---5.00K

Net cash flow from investment products

----

--591.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

---64.00K

97.32%-8.00K

----

---298.00K

----

100.00%0.00

--591.00K

--0.00

-100.00%0.00

-460.00%-18.00K

--0.00

--809.00K

--5.00K

Financing cash flow

Cash flow from continuous financing activities

77.15%19.74M

-105.67%-240.00K

-52.55%2.31M

-109.75%-2.56M

707.46%11.14M

711.30%4.24M

-24.53%4.87M

818.29%26.31M

19.17%1.38M

-47.80%522.00K

--6.45M

223.97%2.87M

--1.16M

-94.58%1.00M

--0.00

---2.31M

--0.00

--18.44M

Net cash flow from debt Issuance/repayment

--20.00M

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

41.69%-1.34M

--1.34M

-100.10%-1.00K

---350.00K

---2.30M

----

732.91%1.00M

--0.00

---158.00K

Net cash flow from common stock issuance/repurchase

-102.33%-260.00K

-105.67%-240.00K

-57.46%2.31M

-109.26%-2.56M

27757.50%11.14M

--4.24M

-46.13%5.43M

306.29%27.69M

-96.55%40.00K

--0.00

--10.08M

--6.81M

--1.16M

-100.00%0.00

--0.00

----

--17.25M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

88.76%-562.00K

----

--0.00

---5.00M

-9.33%-1.65M

----

--0.00

---1.51M

----

--0.00

Proceeds from issuance of warrants

----

-100.00%0.00

----

--523.00K

--1.72M

----

-100.00%0.00

--0.00

----

--2.77M

Net cash flow from other financing activities

----

--0.00

----

--0.00

----

---40.00K

100.00%0.00

--0.00

100.00%0.00

---2.00K

100.00%0.00

--0.00

---800.00K

----

---1.42M

Net cash from non-recurrent financing activities

Net cash from financing activities

77.15%19.74M

-105.67%-240.00K

-52.55%2.31M

-109.75%-2.56M

707.46%11.14M

711.30%4.24M

-24.53%4.87M

818.29%26.31M

19.17%1.38M

-47.80%522.00K

--6.45M

223.97%2.87M

--1.16M

-94.58%1.00M

--0.00

---2.31M

--0.00

--18.44M

Net cash flow

Beginning cash balance

-24.81%14.69M

-8.49%16.90M

-7.45%17.80M

8779.49%27.70M

11666.87%19.53M

1219.73%18.46M

4479.29%19.23M

5.76%312.00K

-91.82%166.00K

-64.55%1.40M

-94.53%420.00K

-97.97%295.00K

-89.62%2.03M

-29.33%3.95M

--7.68M

--14.54M

--19.55M

--5.58M

Current period cash flow changes

85.11%15.13M

-306.45%-2.21M

-17.66%-906.00K

-152.34%-9.90M

5496.58%8.17M

186.78%1.07M

-178.65%-770.00K

15036.80%18.92M

108.42%146.00K

35.68%-1.23M

126.24%979.00K

101.82%125.00K

65.40%-1.73M

-113.72%-1.92M

---3.73M

---6.87M

---5.01M

--13.97M

Effect of exchange rate changes

79.72%-58.00K

278.17%1.28M

199.49%194.00K

-979.65%-1.86M

-273.33%-286.00K

508.43%339.00K

-105.26%-195.00K

29.51%-172.00K

-46.60%165.00K

81.68%-83.00K

-114.03%-95.00K

29.89%-244.00K

575.38%309.00K

-198.03%-453.00K

--677.00K

---348.00K

---65.00K

---152.00K

Ending cash balance

7.61%29.81M

-24.81%14.69M

-8.49%16.89M

-7.45%17.80M

8779.49%27.70M

11666.87%19.53M

1219.73%18.46M

4479.29%19.23M

5.76%312.00K

-91.82%166.00K

-64.55%1.40M

-94.53%420.00K

-97.97%295.00K

-89.62%2.03M

--3.95M

--7.68M

--14.54M

--19.55M

Free cash flow

---4.56M

7.22%-3.25M

----

-109.57%-3.50M

----

32.14%-1.67M

-35.37%-5.97M

40.68%-2.50M

44.38%-3.20M

42.95%-2.46M

---4.41M

---4.21M

---5.75M

---4.32M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Allarity Therapeutics Inc Generate?



Allarity Therapeutics Inc generated -14.82M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Allarity Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Allarity Therapeutics Inc's operating cash flow increased by 14.59% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Allarity Therapeutics Inc Spend on Capital Expenditures?



Allarity Therapeutics Inc spent 8.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Allarity Therapeutics Inc's Financing Cash Flow Changed?



Allarity Therapeutics Inc used 10.65M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ALLR?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Allarity Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -14.83M reflecting a 15.99% change from the previous year.